Pub. Date : 1995 Mar
PMID : 7775863
6 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Apolipoprotein E isoforms and rare mutations: parallel reduction in binding to cells and to heparin reflects severity of associated type III hyperlipoproteinemia. | Heparin | apolipoprotein E | Homo sapiens |
| 2 | Heparin binding studies with the same variants showed a parallel reduction in proteoglycan binding (apoE-2(158), 58.2% of apoE-3; apoE-1(127,158), 37.9%; apoE-1(146), 20.6%). | Heparin | apolipoprotein E | Homo sapiens |
| 3 | Heparin binding studies with the same variants showed a parallel reduction in proteoglycan binding (apoE-2(158), 58.2% of apoE-3; apoE-1(127,158), 37.9%; apoE-1(146), 20.6%). | Heparin | apolipoprotein E | Homo sapiens |
| 4 | Heparin binding studies with the same variants showed a parallel reduction in proteoglycan binding (apoE-2(158), 58.2% of apoE-3; apoE-1(127,158), 37.9%; apoE-1(146), 20.6%). | Heparin | apolipoprotein E | Homo sapiens |
| 5 | Heparin binding studies with the same variants showed a parallel reduction in proteoglycan binding (apoE-2(158), 58.2% of apoE-3; apoE-1(127,158), 37.9%; apoE-1(146), 20.6%). | Heparin | apolipoprotein E | Homo sapiens |
| 6 | The functionally dominant mutation apoE-1(146) was most defective in heparin binding studies in vitro. | Heparin | apolipoprotein E | Homo sapiens |